Detalhe da pesquisa
1.
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Blood
; 142(23): 1960-1971, 2023 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647654
2.
Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
Intern Med J
; 52(10): 1717-1723, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028145
3.
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.
Blood
; 125(6): 915-23, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519749
4.
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Haematologica
; 102(2): 356-363, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143954
5.
The role of intravenous immunoglobulin in treatment of refractory Felty syndrome c.
Intern Med J
; 51(2): 303-304, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631851
6.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Blood
; 120(8): 1570-80; quiz 1752, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715121
7.
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
Blood Cancer J
; 14(1): 54, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531863
8.
Effective Removal of κ-Free Light Chains with Hemodialysis Using Fresenius Ultraflux® EMiC®2 Dialyser in a Patient with Myeloma Cast Nephropathy, with Associated Cost Savings.
Blood Purif
; 42(2): 158-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270690
9.
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.
Leuk Lymphoma
; 61(1): 91-97, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512531
10.
Efficacy and safety of nilotinib 300â¯mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift study.
Leuk Res
; 67: 109-115, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29494928
11.
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.
Blood Adv
; 7(11): 2580-2585, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075018
12.
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
J Clin Oncol
; 35(15): 1678-1685, 2017 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368672
13.
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
Lancet Haematol
; 2(9): e357-66, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26685769
14.
'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
Leuk Lymphoma
; 59(6): 1514-1516, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022836
15.
A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study.
Lancet
; 359(9312): 1114-9, 2002 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-11943260
16.
CXCR4 but not CXCR3 expression correlates with lymphocyte counts in B-cell chronic lymphocytic leukemia.
Ann Hematol
; 83(5): 326-7, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14986066